YaoGeJu

Company directoryChina company filings

Huisheng Biopharmaceutical Co., Ltd.

As of 20 November 2026, for the company name Huisheng Biopharmaceutical Co., Ltd. as recorded, 4 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 41 records, across 22 drug names; the chemical-drug catalogue lists 18 active records with this name as holder.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

41 acceptance records as first applicant, grouped into 22 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

德谷胰岛素注射液 · No verified English name 4 records · Latest accepted 2026/05/08

Supplement · 2New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYSB2600140Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CYSB2600139Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSS2200067New drug2022/07/15Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSS2200066New drug2022/07/15Huisheng Biopharmaceutical Co., Ltd.CDE ↗
德谷门冬双胰岛素注射液 · No verified English name 4 records · Latest accepted 2026/05/08

Supplement · 2New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYSB2600138Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CYSB2600137Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSS2300029New drug2023/05/07Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSS2300028New drug2023/05/07Huisheng Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name 5 records · Latest accepted 2025/08/16

New drug · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSS2500084New drug2025/08/16Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSS2500083New drug2025/08/16Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSL2400394New drug2024/06/15Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSL2400393New drug2024/06/15Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXSL2300274New drug2023/04/20Huisheng Biopharmaceutical Co., Ltd.CDE ↗
P052注射液 · No verified English name 2 records · Latest accepted 2025/07/04

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500638New drug2025/07/04Huisheng Biopharmaceutical Co., Ltd.CDE ↗
CXHL2500637New drug2025/07/04Huisheng Biopharmaceutical Co., Ltd.CDE ↗
Repaglinide Tablets 3 records · Latest accepted 2024/11/05

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403754Generic2024/11/05Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2403753Generic2024/11/05Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2403752Generic2024/11/05Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Dapagliflozin Tablets 2 records · Latest accepted 2023/11/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303090Generic2023/11/10Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2303089Generic2023/11/10Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Linagliptin Tablets 1 records · Latest accepted 2023/09/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302436Generic2023/09/11Huisheng Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanizedCDE ↗
Empagliflozin Tablets 2 records · Latest accepted 2023/08/17

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302170Generic2023/08/17Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2302169Generic2023/08/17Huisheng Biopharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
德谷胰岛素利拉鲁肽注射液 · No verified English name 1 records · Latest accepted 2023/07/26

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSL2300515New drug2023/07/26Huisheng Biopharmaceutical Co., Ltd.CDE ↗
Epalrestat Tablets 1 records · Latest accepted 2023/05/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301215Generic2023/05/06Huisheng Biopharmaceutical Co., Ltd.; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanizedCDE ↗
Calcium Dobesilate Capsules 1 records · Latest accepted 2022/10/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201783Generic2022/10/20Huisheng Biopharmaceutical Co., Ltd.; NORTH CHINA PHARMACEUTICAL COMPANY.LTDCDE ↗
西格列汀二甲双胍片(I) · No verified English name 1 records · Latest accepted 2022/09/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201495Generic2022/09/09Huisheng Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanizedCDE ↗
Sitagliptin Phosphate and Metformin Hydrochloride Tablets (II) 1 records · Latest accepted 2022/09/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201496Generic2022/09/09Huisheng Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanizedCDE ↗
Vildagliptin Tablets 1 records · Latest accepted 2022/08/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201303Generic2022/08/16Huisheng Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanizedCDE ↗
加格列净片 · No verified English name 4 records · Latest accepted 2022/02/28

New drug · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2200015New drug2022/02/28Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
CXHS2200014New drug2022/02/28Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
CXHS2200013New drug2022/02/28Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
CXHS2200012New drug2022/02/28Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
Mecobalamin Injection 1 records · Latest accepted 2022/01/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200225Generic2022/01/28Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
门冬胰岛素30注射液 · No verified English name 1 records · Latest accepted 2022/01/28

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSS2200009New drug2022/01/28Huisheng Biopharmaceutical Co., Ltd.CDE ↗
门冬胰岛素注射液 · No verified English name 1 records · Latest accepted 2022/01/28

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSS2200008New drug2022/01/28Huisheng Biopharmaceutical Co., Ltd.CDE ↗
门冬胰岛素50注射液 · No verified English name 1 records · Latest accepted 2022/01/26

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSS2200007New drug2022/01/26Huisheng Biopharmaceutical Co., Ltd.CDE ↗
Sitagliptin Phosphate Tablets 2 records · Latest accepted 2021/12/27

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2102290Generic2021/12/27Huisheng Biopharmaceutical Co., Ltd.; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanizedCDE ↗
CYHS2102289Generic2021/12/27Huisheng Biopharmaceutical Co., Ltd.; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanizedCDE ↗
Thioctic Acid Injection 1 records · Latest accepted 2021/10/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101836Generic2021/10/11Huisheng Biopharmaceutical Co., Ltd.; Beijing Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
Mecobalamin Tablets 1 records · Latest accepted 2021/09/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101716Generic2021/09/13Huisheng Biopharmaceutical Co., Ltd.; Jilin Si Huan Ao Kang Pharma Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
德谷门冬双胰岛素注射液 · No verified English name CYSB2600138Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
德谷门冬双胰岛素注射液 · No verified English name CYSB2600137Supplement2026/05/08Huisheng Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXSS2500084New drug2025/08/16Huisheng Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXSS2500083New drug2025/08/16Huisheng Biopharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

18 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Repaglinide TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202639972026/04/14Generic approved under the new chemical-drug registration classificationCDE ↗
Repaglinide TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202639982026/04/14Generic approved under the new chemical-drug registration classificationCDE ↗
Repaglinide TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202639992026/04/14Generic approved under the new chemical-drug registration classificationCDE ↗
Dapagliflozin TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202539332025/04/15Generic approved under the new chemical-drug registration classificationCDE ↗
Dapagliflozin TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202539342025/04/15Generic approved under the new chemical-drug registration classificationCDE ↗
Empagliflozin TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202498362024/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Linagliptin TabletsHuisheng Biopharmaceutical Co., Ltd.Tianjin Han Rui Pharma Co., Ltd. romanized国药准字H202498022024/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Empagliflozin TabletsHuisheng Biopharmaceutical Co., Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202498372024/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Epalrestat TabletsHuisheng Biopharmaceutical Co., Ltd.Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized国药准字H202493802024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Calcium Dobesilate CapsulesHuisheng Biopharmaceutical Co., Ltd.—国药准字H202440552024/06/18Generic approved under the new chemical-drug registration classificationCDE ↗
Sitagliptin Phosphate and Metformin Hydrochloride Tablets (II)Huisheng Biopharmaceutical Co., Ltd.Tianjin Han Rui Pharma Co., Ltd. romanized国药准字H202438022024/05/21Generic approved under the new chemical-drug registration classificationCDE ↗
西格列汀二甲双胍片(I) · No verified English nameHuisheng Biopharmaceutical Co., Ltd.Tianjin Han Rui Pharma Co., Ltd. romanized国药准字H202438012024/05/21Generic approved under the new chemical-drug registration classificationCDE ↗
Vildagliptin TabletsHuisheng Biopharmaceutical Co., Ltd.Tianjin Han Rui Pharma Co., Ltd. romanized国药准字H202431592024/02/06Generic approved under the new chemical-drug registration classificationCDE ↗
Mecobalamin InjectionHuisheng Biopharmaceutical Co., Ltd.Beijing Si Huan Pharmaceutical Co., Ltd. romanized国药准字H202341162023/09/05Generic approved under the new chemical-drug registration classificationCDE ↗
Sitagliptin Phosphate TabletsHuisheng Biopharmaceutical Co., Ltd.Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized国药准字H202339032023/06/30Generic approved under the new chemical-drug registration classificationCDE ↗
Sitagliptin Phosphate TabletsHuisheng Biopharmaceutical Co., Ltd.Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized国药准字H202339022023/06/30Generic approved under the new chemical-drug registration classificationCDE ↗
Thioctic Acid InjectionHuisheng Biopharmaceutical Co., Ltd.Beijing Si Huan Pharmaceutical Co., Ltd. romanized国药准字H202337662023/06/21Generic approved under the new chemical-drug registration classificationCDE ↗
Mecobalamin TabletsHuisheng Biopharmaceutical Co., Ltd.Jilin Si Huan Ao Kang Pharma Co., Ltd. romanized国药准字H202335712023/05/19Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.